Article
Cover
Journal Cover Page

RGUHS Nat. J. Pub. Heal. Sci Vol: 14  Issue: 4 eISSN:  pISSN

Article Submission Guidelines

Dear Authors,
We invite you to watch this comprehensive video guide on the process of submitting your article online. This video will provide you with step-by-step instructions to ensure a smooth and successful submission.
Thank you for your attention and cooperation.

Editorial Article
P S Shankar*,1,

1P S Shankar, Editor-in-Chief, RJMS, Emeritus Professor of Medicine, Rajiv Gandhi University of Health Sciences, & KBN University, Kalaburagi, Karnataka, India

*Corresponding Author:

P S Shankar, Editor-in-Chief, RJMS, Emeritus Professor of Medicine, Rajiv Gandhi University of Health Sciences, & KBN University, Kalaburagi, Karnataka, India, Email: drpsshankar@gmail.com
Received Date: 2024-09-10,
Accepted Date: 2024-10-20,
Published Date: 2024-10-30
Year: 2024, Volume: 14, Issue: 4, Page no. 161-164, DOI: 10.26463/rjms.14_4_3
Views: 128, Downloads: 7
Licensing Information:
CC BY NC 4.0 ICON
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0.
Abstract

None

<p>None</p>
Keywords
None
Downloads
  • 1
    FullTextPDF
Article

In recent months (May-August 2024), a rare, fatal form of amoebiasis, referred to as ‘Primary amoebic meningoencephalitis’ (PAM, PAME) was identified in Kerala. Five cases were recognized, all of which resulted in death. The last case was caused by Vermamoeba vermiformis (a free-living amoeba), while others were due to Naegleria fowleri infection.

We are familiar about amoebic dysentery caused by Entamoeba histolytica. Rarely, Acanthamoeba may cause severe corneal inflammation (keratitis) among those wearing contact lenses, while Entamoeba gingivitis, a protozoan parasite living in oral cavity, can lead to persistent gingivitis.1,2

Four cases of PAM, three in children and one in an adult, were first identified in Adelaide, Australia by Fowler and Carter. Autopsy findings indicated that the causative agent likely entered the CNS through the olfactory nerve filaments.3 The first reported case of PAM in India was recorded in Kolkata in 1971, involving two children.4

A fatal case of PAM in a 5-month-old infant was reported from Mangaluru in 2002 and well water used for bathing was found to be the source.5 First case of PAM in Kerala was reported in Alappuzha, in 2016. High mortality rate was due to the rapid onset of illness, delayed diagnosis and lack of effective treatment protocol.6 In Tamil Nadu, a case of PAM in a 47-year-old male was reported, who probably contacted the infection while bathing in a river and he responded to administration of Liposomal

Amphotericin B and Azithromycin.7 A case of PAM in a 20 year old male with acute leukemia in remission, without any history of swimming, was reported from Haryana in 2009 and the patient met a fatal end.8 Jain et al. reported a case of acute meningoencephalitis caused by N. fowleri who made full recovery following treatment with Amphotericin B, Rifampicin and Omidazol.9

Singh et al. reported a case of an 8-year-old boy in Delhi with Naegleria meningitis. The patient was treated with Amphotericin B and Rifampicin in 1998 and survived.10 Kaushal et al. reported a case of a 36-year-old person with a history of bathing in the village pond, succumbing despite the treatment.11 Gupta et al. reported a case of primary amoebic meningoencephalitis in 2015,  while Mittal et al. reported a case of an infant diagnosed with PAM infection in Faridabad, Haryana in 2019.12,13

Thus, multiple cases of PAM have been reported from various parts of India, affecting individuals from infancy to middle age. Many of them did not provide a history of swimming or diving, but reported bathing using well water, or tap water. The response to the treatment has been variable. Though the reports suggested positive response to the treatment in the initial five decades, there have been reports of unresponsiveness to treatment in the recent years, which is intriguing.

Popularly known as ‘the brain-eating amoeba’, Naegleria fowleri is an amoeboflagellate which is responsible for an acute fulminant, rapidly fatal infection of the central nervous system (CNS),  that has been termed as ‘Primary amoebic meningoencephalitis’. The condition is considered as a rare, neglected one.

Naegleria fowleri, a species of Naegleria, is a one celled, amoeboflagellate, that is ubiquitously distributed worldwide in different warm aquatic environments, mud and soil. It is found in warm freshwater lakes, water ponds, hot springs, irrigation canals, poorly maintained swimming pools, and rivers.2 This thermophilic amoeba grows in fresh water bodies of tropical and subtropical climates, with high temperature and humidity. N. fowleri was found in various water bodies in Rohtak and Jhajjar districts of Haryana. About 107 water samples from the trapped debris of water reservoirs were screened. Among these, 43 (40%) samples showed the presence of free living amoeba after incubation for 14 days at 37oC, while one sample showed the growth of N. fowleri and another sample showed growth of N. australiencis.14

The infection can be acquired from water-related activities such as swimming, jumping or diving. The condition often affects children and young persons, mostly male, who are active and healthy. The pathogen was also isolated from a swimming pool in Bombay (now called Mumbai).15 N. fowleri was also found in pond water and sewage water in Calcutta (now called Kolkata).16,17

Although N. fowleri is commonly found in the environment, rarely it causes an infection. N. fowleri is a heat-loving, single-celled amoeba in the phylum of protozoa (single-celled infective organism) called ‘Percolozoa’. It has been noted as a free-living organism in freshwater and soil, and it thrives by consuming organic matter and bacteria. The organism passes through three different stages in its life cycle, such as cyst, flagellate, and amoeboid trophozoite. Cysts are highly stable and can withstand any environment. The f lagellate form is an intermediate stage that has the ability to move quickly from a hostile surrounding. The amoeboid trophozoite form is the active, eating, and reproducing phase. Animals and humans are considered ‘accidental hosts’.

Naegleria are ‘thermophilic’ and exhibit marked activity in warm water during summer months. They are found in both tropical and temperate climates throughout the world. They get encysted in situations where the water temperature is cool; often the protective cyst forms are found in the sediment at the bottom of lakes. In such surroundings, they can survive winters. The most infectious form is the trophozoite form. However, cysts may assume an infectious state within few hours when the conditions get favourable. The flagellated form can become a trophozoite within minutes.

Often the organism has been reported in poorly chlorinated and unchlorinated swimming pools. Its presence has been noted in water parks using nonchlorine-based water treatment methods. It is important to note that N. fowleri cannot survive in saltwater. It is not found in the ocean.

The organism enters through the nose when the water contaminated with trophozoites make an entry into the nose.2 Occasionally, the infection can occur through a damaged ear drum. Rarely contaminated tap water may cause the infection during nasal rinsing.18 The trophozoites enter the CNS through the nose, after insufflations of infected water. It gets attached to the olfactory nerves, passes through the cribriform plate of the ethmoid bone into the anterior cerebral fossae.19

The infection can lead to severe necrosis of the olfactory bulb and brain. Probably a chemical agent does not lure N. fowleri by chemotaxis towards the brain.20 The infection is neither contracted by drinking water contaminated with N. fowleri, nor does it spread from person-to-person contact.

The trophozoites are found in an amoebic form. Amoeba is a unicellular organism without any fixed shape. They move by forming pseudopods and feed on bacteria and detritus. In hostile environments such as hypotonic water, it assumes a flagellate form to escape from the region, and if the environment continues to remain hostile, it assumes a cystic form.2

Naegleria is a facultative parasite that does not require any host to complete its life cycle and it reproduces by mitosis.

After an incubation period of 3 to 7 days, the infection suddenly presents with severe symptoms. It presents with frontal headache unresponsive to analgesics, high fever, runny nose, alteration in taste and smell, nausea, vomiting, and neck stiffness. Later the patient exhibits behavioural changes, sensitivity to light, and drowsiness. The condition can rapidly deteriorate within a week causing coma and death. The condition progresses through three stages during the course of the disease.

Stage I: Nasal (Precerebral) stage

Stage II: Olfactory stage

Stage III: Meningoencephalitis stage

Minimal inflammation is noted in the nose, while brain shows severe inflammation with infiltration of neutrophils, eosinophils, monocytes and macrophages.21 The detection of amoebae by the immune system is impaired as the agent is eukaryotic, similar to the host cell.

The diagnosis is made using microscopic and molecular methods (PCR and ELISA). The symptoms are non-specific and often confused with disorders such as bacterial & viral encephalitis, and pyogenic meningoencephalitis. These conditions must to be considered in differential diagnosis. The cerebrospinal f luid (CSF) obtained from lumbar puncture aids in establishing the diagnosis. The CSF comes out with very high pressure. There is elevated levels of protein and reduced levels of sugar. There is increased number of leucocytes with polymorphonuclear cell predominance. There can also be presence of red blood cells. A definite diagnosis is made by identifying motile trophozoites of 10 to 25 microns size with a single nucleus and a centrally located nucleolus without any peripheral chromatin, in the centrifuged wet mount preparation. The morphological features of the trophozoites are established using Wright-Giemsa stain. Enflagellation test is performed by addition of 0.5 mL CSF to 2 mL distilled water on a sterile flat-bottomed plate and is incubated at 37oC. Microscopy undertaken at 15-minute intervals may show motile moving organisms exhibiting a unique flagellate pattern.22

Magnetic resonance imaging (MRI) of the brain reveals the presence of one or more space-occupying lesions with ring enhancement.23 Polymerase chain reaction (PCR) helps to determine the genetic material of the amoeba.

Autopsy reveals extensive hemorrhages and necrosis of the brain, especially on the frontal cortex.

PAM exhibits an extremely high mortality rate varying between 95-98% and the percentage of mortality has remained same over the last six decades.

There is no proven therapy for N. fowleri infection. The Centre for Disease Control and Prevention (CDC) has made recommendations to use the antifungal drug, Amphotericin B in high doses and must be administered intrathecally.24 Many other drugs that have been tried in the treatment include Fluconazole, Chloramphenicol, Dexamethasone, Miconazol, Rifampicin, and Miltefosine.

Cure for this condition is very rare. Various studies have shown that the drugs may be effective if administered early. However, early diagnosis is often difficult and the condition progresses rapidly. PAE is a severe form of a rare disease.

In India, the cases do not appear to be water related as many of the reported cases did not provide a history of swimming. Many bathed using well or pond water. Climate change may play an important role in the spread of the disease.25 Rai et al. reported a case of an 8-month old infant who was bathed regularly using pond water, had acquired the infection. The child responded to the treatment with Amphotericin B, Chloramphenicol and Rifampicin.26

Public water supplies, swimming pools, and pools in theme parks should be meticulously cleaned and chlorinated regularly with levels high enough to protect against N. fowleri. Forced water at the level of nose must be avoided. Nasal irrigation should be carried out with water that is sterile. The risk of infection can be reduced by wearing nose clips while swimming. Bathing in stagnant water and diving in water should be avoided.

The condition takes a rapid course making it difficult to initiate specific treatment for the disease. Yadav and colleagues have reported a case of youngest survivor of Naegleria meningitis infection. A 25-day old baby received Amphotericin B, Rifampicin and Fluconazole for four weeks, made recovery without any residual disability.27

Given the rapid progression of the infection and the associated high mortality rate, it is crucial to make every effort for early diagnosis and prompt treatment with specific medicines. The physicians should be aware of this condition when encountering cases of meningitis or meningo-encephalitis. This enables them to make an early diagnosis and initiate treatment with a broad range of drugs in a timely manner.

Conflict of Interest

None

 

Supporting File
No Pictures
References
  1. Visvesvara GS. Amoebic meningoencephalitides and keratitis: challenges in diagnosis and treatment. Curr Opin Infect Dis 2010;23(6):590-4.
  2. Borkens Y. The pathology of Brain-eating amoeba: Naeglaria fowleri. Indian J Microbiol 2024;64(3):1384-1394.
  3. Fowler M, Carter RF. Acute pyogenic meningitis probably due to Acanthamoeba sp: A preliminary report. Br Med J 1965;2:740-742.
  4. Pan NR, Roy BC, Ghosh TN. Primary amoebic meningo-encephalitis in two Indian children. J Indian Med Assoc 1971;56:134-7.
  5. Shenoy S, Wilson G, Prashanth HV, et al. Primary meningoencephalitis by Naeglaria Fowleri: First reported case from Mangalore, South India. J Clin Microbiol 2002;40:309-310.
  6. Regu K, Rajendran R, Bhaskaran KS, et al. Primary amoebic meningoencephalitis in Kerala - An emerging public health concern. J Commun Dis 2024;56:25-35.
  7. Perumalsamy V, Sundaramoorthy R, Ganesan V, et al. Survival of primary amebic meningoencephalitis by Naegleria fowleri: First reported case from Tamil Nadu, South India. Trop Parasitol 2020;10:150-152.
  8. Gupta N, Bhaskar H, Duggal S, et al. Primary amoebic meningoencephalitis: first reported case from Rohtak, North India. Braz J Infect Dis 2009;13(3):236-7.
  9. Jain R, Prabhakar S, Modi M, et al. Naegleria meningitis: a rare survival. Neurol India 2002; 50(4):470-472.
  10. Singh SN, Patwari AK, Dutta R, et al. Naegleria meningitis. Indian Pediatr 1998;35(10):1012-15.
  11. Kaushal V, Chhina DK, Ram S, et al. Primary amoebic meningoencephalitis due to Naegleria fowleri. J Assoc Physicians India 2008;56:459-82.
  12. Gupta R, Parashar MK, Kale A. Primary amoebic meningoencephalitis. J Assoc Physicians India 2015;63:69-71. 
  13.  Mittal N, Mahajan L, Hussain Z, et al. Primary amoebic meningoencephalitis in an infant. Indian J Med Microbiol 2019;37:120-2.
  14. Panda A, Khalil S, Mirdha BR, et al. Prevalence of Naegleria fowleri in environmental samples of Northern part of India. PLoS One 2015; 10(10):e0137736.
  15. Gogate A, Deodhar L. Isolation and identification of pathogenic Naegleria fowleri (aerobia) from a swimming pool in Bombay. Trans R Soc Trop Med Hyg 1985;79:134.
  16. Gupta S. Isolation of Naegleria fowleri from pond water in west Bengal, India. Trans R Soc Trop Med Hyg 1992;86:46.
  17. Bose K, Ghosh DK, Ghosh KN, et al. Characterization of potentially pathogenic free-living amoebae in sewage samples of Calcutta, India. Braz J Med Biol Res 1990;23:1271-8. 
  18. Güémez A, García E. Primary amoebic meningoencephalitis by Naegleria fowleri: Patho-genesis and treatments. Biomolecules 2021; 11:1320. 
  19. Rohr U, Weber S, Michel R, et al. Comparison of free-living amoebae in hot water systems of hospitals with isolates from moist sanitary areas by identifying generaand determining temperature tolerance. Appl Environ Microbiol 1998;64: 1822-1824.
  20. Baig AM. Primary amoebic meningoencephalitis: Neurochemotaxis and neurotropic preferences of Naegleria fowleri. ACS Chem Sci 2016;7(8):1026-1029.
  21. Gyori E. December 2002: 19-year-old male with febrile illness after jet ski accident. Brain Pathol 2003;13(2):237-9.
  22. Pugh JJ, Levy RA. Naegleria fowleri: Diagnosis, pathophysiology of brain inflammation, and antimicrobial treatments. ACS Chem Neurosci 2016;21:1178-9.
  23. Visvesvara GS. Infections with free-living amebae. Handb Clin Neurol 2013;114:153-68.
  24. Burki A, Satti L, Mahboob S, Anwar S, Bizanjo M, Rafique M, et al. Successful Treatment of Confirmed Naegleria fowleri Primary Amebic Meningoencephalitis. Emerg Infect Dis. 2024;30 (4):803-805.
  25. Moseman EA. Battling brain-eating amoeba: enigmas surrounding immunity to Naegleria fowleri. PLoS Pathog 2020;16(4):e1008406.
  26. Rai R, Singh DK, Srivastava AK, et al. Primary amoebic meningoencephalitis. Indian Pediatr 2008;15:1004-1005.
  27. Yadav D, Aneja S, Dutta R, et al. Youngest survivor of Naegleria meningitis. Indian J Pediatr 2013;80(3):253-4.
HealthMinds Logo
RGUHS Logo

© 2024 HealthMinds Consulting Pvt. Ltd. This copyright specifically applies to the website design, unless otherwise stated.

We use and utilize cookies and other similar technologies necessary to understand, optimize, and improve visitor's experience in our site. By continuing to use our site you agree to our Cookies, Privacy and Terms of Use Policies.